Skip to main content
. 2022 Jan 18;11:783335. doi: 10.3389/fonc.2021.783335

Figure 3.

Figure 3

Comparisons of survival among patients with different status of PD-1 and PD-L1 expression in 154 unselected HCC patients who received adjuvant sorafenib. Kaplan–Meier curves of OS and RFS according to expression of PD-1 (A, B) and PD-L1 (C, D).